This review briefly explains the relevant regulatory history of software as medical devices (SaMDs) and reviews the current regulatory landscape in which prescription and non-prescription digital therapeutics are developed and approved for use.
FDA regulations and prescription digital therapeutics: Evolving with the technologies they regulate